Related Experiment Videos
Experimental study of antiblastic activity in potentiated antibodies to tumor necrosis factor-alpha
E N Amosova1, E P Zueva, T G Razina
1Institute of Pharmacology, Tomsk Research Center, Siberian Division of the Russian Academy of Medical Sciences.
Bulletin of Experimental Biology and Medicine
|September 2, 2003
Abstract:
In mice with Lewis lung carcinoma and melanoma B-16 administration of potentiated antibodies to tumor necrosis factor-alpha started 1 day after transplantation of a small number of tumor cells (10(6)) produced an antiblastic effect.